These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Optimal induction of upper respiratory tract immunity to reovirus 1/L by combined upper and lower respiratory tract inoculation. Thompson AH; McRoberts JG; Crowe SR; London L; London SD Vaccine; 1999 Mar; 17(11-12):1404-15. PubMed ID: 10195776 [TBL] [Abstract][Full Text] [Related]
13. The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines. Kurono Y Auris Nasus Larynx; 2022 Feb; 49(1):1-10. PubMed ID: 34304944 [TBL] [Abstract][Full Text] [Related]
14. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible? Marasini N; Kaminskas LM Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591 [TBL] [Abstract][Full Text] [Related]
15. Intranasal formulations: promising strategy to deliver vaccines. Riese P; Sakthivel P; Trittel S; Guzmán CA Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722 [TBL] [Abstract][Full Text] [Related]
16. Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants. Takaki H; Ichimiya S; Matsumoto M; Seya T J Innate Immun; 2018; 10(5-6):515-521. PubMed ID: 29860261 [TBL] [Abstract][Full Text] [Related]
17. Development of a nanogel-based nasal vaccine as a novel antigen delivery system. Nakahashi-Ouchida R; Yuki Y; Kiyono H Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938 [TBL] [Abstract][Full Text] [Related]
18. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine? Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584 [TBL] [Abstract][Full Text] [Related]
19. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route. Li R; Lim A; Alonso S Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832 [TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection. Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J Front Immunol; 2022; 13():995235. PubMed ID: 36172368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]